Expand SXTPW Menu
SXTPW MENU

SXTPW Latest Press Releases

-- September 3, 2026 --

60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference Globe Newswire 8:04 AM

-- August 14, 2026 --

60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results Globe Newswire 3:47 PM

-- July 30, 2026 --

60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules Globe Newswire 2:23 PM

-- July 29, 2026 --

60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026 Globe Newswire 4:03 PM

-- July 8, 2026 --

60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases Globe Newswire 8:01 AM

-- July 1, 2026 --

60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue Globe Newswire 8:02 AM

-- June 11, 2026 --

60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement Globe Newswire 8:03 AM

-- May 26, 2026 --

60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis Globe Newswire 8:02 AM

-- May 15, 2026 --

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results Globe Newswire 8:42 AM
Market Data Delayed 15 Minutes